Skip to main content
Erschienen in: BMC Gastroenterology 1/2016

Open Access 01.12.2016 | Research article

A meta-analysis of long follow-up outcomes of laparoscopic Nissen (total) versus Toupet (270°) fundoplication for gastro-esophageal reflux disease based on randomized controlled trials in adults

verfasst von: Xing Du, Zhiwei Hu, Chao Yan, Chao Zhang, Zhonggao Wang, Jimin Wu

Erschienen in: BMC Gastroenterology | Ausgabe 1/2016

Abstract

Background

Laparoscopic Nissen fundoplication (LNF) is the most common surgical procedure for the surgical management of gastro-esophageal reflux disease (GERD). Laparoscopic Toupet fundoplication (LTF) has been reported to have a lower prevalence of postoperative complications yet still obtain a similar level of reflux control. We conducted a meta-analysis to confirm the value of LNF and LTF.

Methods

PubMed, Medline, Embase, Cochrane Library and Springerlink were searched for randomized controlled trials (RCTs) comparing LNF and LTF. Data regarding the benefits and adverse results of two techniques were extracted and compared using a meta-analysis.

Results

Eight eligible RCTs comparing LNF (n = 625) and LTF (n = 567) were identified. There were no significant differences between LNF and LTF with regard to hospitalization duration, perioperative complications, patient satisfaction, postoperative heartburn, regurgitation, postoperative DeMeester scores, or esophagites. A shorter operative time and higher postoperative lower esophageal sphincter pressure were associated with LNF. Prevalence of postoperative dysphagia, gas-bloating, inability to belch, dilatation for dysphagia and reoperation were higher after LNF, but subgroup analyses showed that differences with respect to dysphagia between LNF and LTF disappeared over time. Subgroup analyses did not support “tailored therapy” according to preoperative esophageal motility.

Conclusions

LNF and LTF have equivalently good control of GERD and result in a similar prevalence of patient satisfaction. Based on current evidence, it is not rational or advisable to abandon LNF when choosing a surgical procedure for GERD.

Background

Gastro-esophageal reflux disease (GERD) is one of the most common gastrointestinal diseases in which the gastric contents flow into the esophagus through the incompetent lower esophageal sphincter (LES) and can cause troublesome symptoms and complications [1]. According to epidemiology studies, GERD affects 10–28 % of Europeans [2] and 3–7 % of Asians [3] (with an increase in prevalence in some Asian countries), which leads to a considerable healthcare burden and low quality of life.
Currently, the therapy approaches of GERD include lifestyle modifications, proton pump inhibitor-based pharmacologic therapy and surgical intervention [4]. Fundoplication has achieved an established role in the management of complicated GERD [57]. In the last two decades, many studies including randomized controlled trials (RCTs) and meta-analyses have shown that laparoscopic surgery is as effective and safe as open surgery for the treatment of GERD, while reducing the hospital stay and incidence of complications [810].
There are two major anti-reflux procedures: 360° total (Nissen) fundoplication and 270° partial (Toupet) fundoplication. Currently laparoscopic Nissen fundoplication (LNF) is the most common surgical procedure for the management of GERD offering promising long-term outcomes [11] and has been recommended as a choice of surgical therapy by the European Study Group for Antireflux Surgery and the Society of American Gastrointestinal Endoscopic Surgeons [12]. Nevertheless, LNF can induce functional disorders, such as dysphagia, gas-bloating and an inability to belch. Compared to LNF, several surgeons have stated that laparoscopic Toupet fundoplication (LTF) has a lower prevalence of postoperative complications while obtaining a similar control of reflux [13], but, several studies have failed to show a significant difference between them [14, 15]. Also, whether preoperative esophageal motility (EM) should be considered when surgeons select a procedure has not been elucidated. Hence, the controversy regarding the optimal surgical method continues.
Several systematic reviews and meta-analyses have compared outcomes between laparoscopic partial fundoplication and LNF up until 2013. However, generalization of all types of partial fundoplication into one category in a review is not appropriate [1618]. In the past 3 years, several RCTs [1921] published comparison between the value of LNF and LTF. Hence, it is necessary to synthesize data from those RCTs with existing RCTs in a meta-analysis to re-evaluate outcomes so that evidence for optimal clinical practice can be provided.

Methods

This meta-analysis was conducted and the results were described according to the PRISMA statement [22].

Search strategy

Following electronic databases were searched till October 2015: PubMed, Medline, Embase, Cochrane Library (issue 10, 2015) and Springerlink. A manual search was also performed to identify trials in the reference lists of the articles acquired. Only articles written in English were searched. A search strategy using disease-specific terms (e.g., gastro-esophageal reflux disease), management-specific terms (e.g., laparoscopic anti-reflux fundoplication) and terms related to surgical procedures (e.g., Nissen, Toupet, total and partial) were adopted.

Inclusion criteria and exclusion criteria

Inclusion criteria were: (i) RCTs comparing efficacy and adverse outcomes of LNF and 270° LTF; (ii) age ≥16 years; (iii) laparoscopic procedure was carried out in all patients; (iv) duration of follow-up ≥12 months; (v) raw data could be extracted from studies to calculate outcomes; (vi) patients were diagnosed definitively preoperatively.
Exclusion criteria were: (i) non-RCTs; (ii) trials comparing total and non-posterior partial fundoplication (e.g., total vs. anterior fundoplication); (iii) fundoplications were carried out with laparotomy; (iv) trials involving patients aged <16 years; (v) studies published repeatedly in different journals; (vi) studies for which raw data could not be extracted to obtain pooled results and the corresponding author could not provide data requested.

Outcomes of interest and definitions

Outcome parameters were described as below. Subjective evaluation: patient satisfaction with the intervention, postoperative heartburn and regurgitation (defined as subjective persistence of reflux and/or recurrence on a dichotomous scale compared with the preoperative state). Objective evaluation: DeMeester scores on 24-h pH monitoring, LES pressure, and endoscopic esophagitis. Prevalence of perioperative complications, postoperative complications, postoperative dilatation for dysphagia, reoperation, operating time, duration of hospitalization, and mortality were also evaluated. Among the outcomes mentioned above, patient satisfaction, postoperative heartburn and dysphagia were regarded as primary outcome parameters, and the others were regarded as secondary outcome parameters.

Data extraction

Two reviewers extracted details from selected studies independently. Data comprised (i) information provided and the quality of the research: first author, publication year, study population characteristics, study design, sample size, follow-up duration, and inclusion/exclusion criteria; and (ii) outcomes analysis, including beneficial and adverse results. Disagreements between reviewers were resolved by discussion and consensus. If data were missing, the authors of the original studies were contacted to provide the relevant information. Outcomes of interest of repeated RCTs in which the study population arose from the same cohort published in different journals at different phases were extracted based on the article that was published most recently.

Statistical analysis

Data extracted from eligible trials were integrated with Review Manager 5.3 provided by the Cochrane Collaboration. Outcomes reported by two or more studies were pooled in the meta-analysis. Dichotomous and continuous outcomes were presented as risk ratio (RR) and standard mean difference (SMD) respectively. Dichotomous outcomes were pooled using the Mantel-Haenszel method, while continuous outcomes were pooled using the inverse variance method. The fixed-effects model was used if heterogeneity was absent (χ2 test, P > 0.1 and I 2  < 50 %); otherwise the random-effects model was used [23]. If excessive heterogeneity was present, data were first rechecked. If heterogeneity persisted, sensitivity or subgroup analyses were undertaken to explore its causes. Subgroup analysis was performed to assess the impact of follow-up duration and EM.

Quality assessment

According to Cochrane criteria guidelines, all included studies were evaluated to ascertain if methodological bias was present [24].

Results

Description of studies

After screening of trials according to inclusion and exclusion criteria, eight RCTs [1921, 2529] were identified, including 1192 patients, of whom 625 (52.43 %) underwent LNF and 567 (47.57 %) underwent LTF (Fig. 1). Included studies were published between 2003 and 2015. Duration of follow-up ranged from 12 to 60 months. Not all studies provided data regarding outcomes of interest. In two trials [19, 27], whether the baseline information of two groups was similar was not clear. Basic characteristics of included RCTs are listed in Table 1.
Table 1
The basic characteristics of included randomized clinical trials
Source
Country
N
Sex ratio
Age (years)
BMI or Weight (Kg)
DSGV
Follow–up
(LNF/LTF)
(Male/Female)
(LNF/LTF)
(LNF/LTF)
(months)
Chrysos 2003[25]
Greece
14/19
18/15
61.7 ± 8.7/59.2 ± 11.5
NR
NO
12
Guérin 2007[26]
Belgium
77/63
86/54
NR
Mean BMI 27.9/27.2
YES
36
Strate 2008[27]
Germany
100/100
121/79
56(20–80)
Median BMI 26.4(18.9–40.4)
YES
24
Booth 2008[28]
England
64/63
84/43
45.3(21–86)/44.2(19–69)
Mean Weight 81.6/80.2
YES
12
Shaw 2010[29]
South Africa
50/50
60/40
45.2(28–72)/45.6(25–67)
Mean BMI 29.3 ± 5.2/29.2 ± 5.2
YES
60
Qin 2013[19]
China
215/168
194/189
56.3(34–82)
NR
NO
12
Koch 2013[20]
Austria
62/63
78/47
50.32(20–76)/51.87(25–81)
Mean BMI 28.18(19.47–41.80)/27.32(19.66–3.86)
YES
12
Wang 2015[21]
China
43/41
44/40
57 ± 13.2/57 ± 10.8
Mean BMI 23.5 ± 2.7/2.5 ± 3.4
YES
24
LNF laparoscopic Nissen fundoplication, LTF laparoscopic Toupet fundoplication, BMI body mass index, DSGV division of short gastric vessels, NR not report

Quality assessment

The methodological quality of included trials is shown in Table 2. Main limitations resulted from poor description of randomization processes [19, 26], as well as a lack of (or poor description of) double-blinding processes [19, 20, 26].
Table 2
Risk of bias summary
 
Chrysos 2003[25]
LR
LR
LR
LR
LR
LR
LR
Guérin 2007[26]
UR
UR
UR
LR
LR
LR
LR
Strate 2008[27]
LR
LR
LR
LR
LR
LR
LR
Booth 2008[28]
LR
LR
LR
LR
LR
LR
LR
Shaw 2010[29]
LR
LR
LR
LR
LR
LR
LR
Qin 2013[19]
HR
LR
UR
UR
LR
LR
LR
Koch 2013[20]
LR
LR
HR
LR
LR
LR
LR
Wang 2015[21]
LR
LR
LR
LR
LR
LR
LR
①:Random sequence generation; ②:Allocation concealment; ③:Blinding of participants and personnel ④:Blinding of outcomes assessment; ⑤:Incomplete outcome data; ⑥:Selective reporting; ⑦:Other bias. LR low risk, UR unclear risk, HR high risk

In-hospital characteristics

Operating time

Six RCTs [19, 21, 25, 2729] reported operating time for LNF and LTF. Because of significant heterogeneity, the random-effects model was used to pool data. Meta-analysis revealed a significant difference in this parameter between the two groups (SMD = –0.54 min, 95 % confidence interval (CI), –0.84 to –0.24 min, P = 0.0004) (Table 3). Operating time was shorter in patients undergoing LNF. Sensitivity analyses were done upon consideration of whether division of the short gastric vessels was a possible cause of heterogeneity. After removal of two studies [19, 25], heterogeneity disappeared and the result did not change (four studies with division of short gastric vessels: SMD = –0.34 min, 95 % CI, –0.51 to –0.16 min, P = 0.0001, χ2 test, P = 0.51, I 2  = 0 %).
Table 3
Meta-analysis of some outcome parameters after LNF and LTF
Outcome
n
Heterogeneity test
Analysis model
SMD (95 % CI) or RR (95 % CI)
P value
LNF
LTF
I 2
P value
Operating time
486
441
77 %
0.0007
Random
SMD –0.54 (–0.84, –0.24)
0.0004
Duration of hospitalization
336
291
13 %
0.28
Fixed
SMD –0.05 (–0.41, 0.32)
0.8
Reoperation
274
282
4 %
0.37
Fixed
RR 3.16 (1.49, 6.68)
0.003
Preoperative DeMeester scores
484
441
0 %
0.45
Fixed
SMD 0.17 (0.02, 0.32)
0.02
Preoperative LES pressure
548
504
20 %
0.29
Fixed
SMD –0.06 (–0.21, 0.09)
0.43
Postoperative esophagitis
317
277
0 %
0.46
Fixed
RR 0.98 (0.81, 1.18)
0.8
LNF laparoscopic Nissen fundoplication, LTF laparoscopic Toupet fundoplication, SMD standard mean difference, RR risk ratio, LES lower esophageal sphincter

Duration of hospitalization

Four studies [19, 21, 25, 28] reported duration of hospitalization after LNF and LTF. Meta-analysis revealed no significant difference in this parameter between the two arms (SMD = –0.05 days, 95 % CI, –0.41 to 0.32 days, P = 0.80) (Table 3).

Perioperative complications

Five studies [21, 2528] reported perioperative complications after LNF and LTF. Meta-analysis revealed no significant difference in this parameter between the two groups (RR = 0.78, 95 % CI, 0.37 to 1.68, P = 0.53) (Fig. 2).

Patient satisfaction

Six trials [21, 2529] reported patient satisfaction after LNF and LTF. Four RCTs counted the number of patients who were “very satisfied”/“satisfied” with the intervention. The other two RCTs employed a Visick scale to measure patient the degree of patient satisfaction. The Visick score ranged from I (excellent) to IV (poor) based on postoperative symptoms [30]. For this report, Visick scale grade I/II was defined as “very satisfied”/“satisfied” with the procedure. Meta-analysis revealed no significant difference in this outcome between the two arms (RR = 1.02, 95 % CI, 0.96 to 1.08, P = 0.49) (Fig. 2).

Recurrence of GERD symptoms and prevalence of reoperation

Postoperative heartburn

Seven studies [19, 21, 2529] reported postoperative heartburn after LNF and LTF. Excessive heterogeneity existed, so the random-effects model was used to pool data. Meta-analysis revealed no significant difference in this parameter between the two arms (RR = 0.88, 95 % CI, 0.48 to 1.64, P = 0.70) (Fig. 2). After removal of one RCT [19], heterogeneity was reduced significantly, and the result did not alter (RR = 1.11, 95 % CI, 0.79 to 1.57, P = 0.54, χ2 test, P = 0.67, I 2  = 0 %).

Postoperative regurgitation

Three studies [21, 25, 28] reported postoperative regurgitation after LNF and LTF. Meta-analysis revealed no significant difference in this outcome between the two groups (RR = 1.18, 95 % CI, 0.54 to 2.60, P = 0.67) (Fig. 2).

Reoperation

Five studies [20, 25, 2729] reported the prevalence of reoperation after LNF and LTF. Meta-analysis revealed a significant difference in this parameter between the two groups (RR = 3.16, 95 % CI, 1.49 to 6.68, P = 0.003) (Table 3). Findings showed a lower prevalence of reoperation after LTF.

Objective outcomes

DeMeester scores

Preoperative DeMeester scores
Six studies [1921, 25, 27, 29] reported preoperative DeMeester scores on 24-h pH monitoring. Meta-analysis revealed a significant difference in this parameter between the two arms (SMD = 0.17, 95 % CI, 0.02 to 0.32, P = 0.02) (Table 3). Slightly higher mean DeMeester scores before LNF were documented.
Postoperative DeMeester scores
The same six studies [1921, 25, 27, 29] mentioned above reported postoperative DeMeester scores on 24-h pH monitoring. Because of significant heterogeneity, the random-effects model was used to pool data. Meta-analysis revealed no significant difference in this parameter between the two arms (SMD = –0.20, 95 % CI, –0.59 to 0.18, P = 0.30) (Fig. 3).

LES pressure

Preoperative LES pressure
Seven studies [1921, 25, 2729] reported preoperative LES pressure. Meta-analysis revealed no significant difference in this parameter between the two groups (SMD = –0.06 mmHg, 95 % CI, –0.21 to 0.09 mmHg, P = 0.43) (Table 3).
Postoperative LES pressure
The same seven studies [1921, 25, 2729] mentioned above reported postoperative LES pressure. Meta-analysis revealed a significant difference in this parameter between the two groups (SMD = 0.61 mmHg, 95 % CI, 0.48 to 0.74 mmHg, P < 0.00001) (Fig. 3). The result suggested that LNF was associated with a higher mean postoperative LES pressure compared to LTF.

Postoperative esophagitis

Three studies [19, 25, 27] reported postoperative esophagitis after LNF and LTF. Meta-analysis revealed no statistically difference in this parameter between the two groups (RR = 0.98, 95 % CI, 0.81 to 1.18, P = 0.80) (Table 3).

Postoperative complications

Postoperative dysphagia

Considering duration of follow-up and EM were possible factors influencing dysphagia, subgroup analyses were conducted based on these factors.
Subgroup analyses of dysphagia based on duration of follow-up
Seven studies [19, 21, 2529] reported postoperative dysphagia, including five studies [19, 21, 25, 27, 28] with duration of follow-up <36 months and two studies [27, 29] with duration of follow-up ≥36 months. When total-group analyses were performed, meta-analysis revealed a significant difference in this parameter between the two arms (RR = 2.75, 95 % CI, 1.69 to 4.50, P < 0.0001) (Fig. 4). Findings showed a lower prevalence of dysphagia for patients who had undergone LTF. In the subgroup with a follow-up <36 months, results also favored LTF (RR = 2.69, 95 % CI, 1.62 to 4.49, P = 0.0001) (Fig. 4). Nevertheless, in the subgroup with a follow-up ≥36 months, the prevalence of postoperative dysphagia was similar between the two groups (RR = 3.47, 95 % CI, 0.58 to 20.60, P = 0.17) (Fig. 4).
Subgroup analyses of dysphagia based on preoperative EM
In the subgroup with normal EM subgroup preoperatively, subgroup analyses revealed a significant difference in the outcomes between the two arms (subgroup 1: RR = 3.15, 95 % CI, 1.25 to 7.94, P = 0.01) (Fig. 4). The result showed a lower prevalence of dysphagia for patients who had undergone LTF. However, in the subgroup with abnormal EM or subgroup of LNF with normal EM and LTF with abnormal EM preoperatively, subgroup analyses failed to find a difference (subgroup 2: RR = 1.88, 95 % CI, 0.88 to 4.02, P = 0.11; subgroup 3: RR = 1.25, 95 % CI, 0.50 to 3.12, P = 0.63) (Fig. 4).

Postoperative dilatation for dysphagia

Four studies [21, 25, 27, 28] reported postoperative dilatation after LNF and LTF. Meta-analysis revealed a significant difference in this parameter between the two arms (RR = 2.99, 95 % CI, 1.22 to 7.35, P = 0.02) (Fig. 5). The result showed that LTF was associated with a slightly lower occurrence of dilatation for dysphagia compared to LNF.

Postoperative gas-bloating

Four studies [21, 25, 27, 28] reported postoperative gas-bloating after LNF and LTF. Meta-analysis revealed a significant difference in this parameter between the two arms (RR = 1.62, 95 % CI, 1.25 to 2.09, P = 0.0002) (Fig. 5). The result showed a lower occurrence of postoperative gas-bloating for patients who underwent LTF.

Postoperative inability to belch

Four studies [21, 2628] reported postoperative inability to belch after LNF and LTF. Meta-analysis revealed a significant difference in this parameter between the two groups (RR = 2.04, 95 % CI, 1.25 to 3.33, P = 0.004) (Fig. 5). The result showed a lower occurrence of the inability to belch for patients who underwent LTF.

Mortality

As no death was associated with these two surgical methods in hospital or during follow-up, the two arms could not be compared with regard to mortality.

Sensitivity analysis

For two studies [19, 27], whether the baseline information of two arms was similar was not known. After removal of these two studies from the pooling analysis, the results did not alter substantially with regard to the primary outcomes: patient satisfaction, postoperative heartburn and postoperative dysphagia.

Discussion

Since the first laparoscopic fundoplication was undertaken for GERD in 1991, laparoscopic surgery has been the “gold standard” for patients with medical-refractory GERD [31]. Although LNF is classic procedure for the treatment of GERD, it is challenged by LTF with less functional disorders.
In the last two decades, several RCTs have been conducted to compare LNF with LTF, but the results have been inconclusive. Between 2010 and 2015, four meta-analyses [3235] comparing LNF with LTF were published. However, in the included trials, LTF was done with various circumferences (200°–270°), which would induce heterogeneity between trials and reduce the reliability and accuracy of the findings of the meta-analyses above. In addition, these meta-analyses neglected the comparability of baseline information of LNF and LTF. Several trials [1921] of large-scale and long-term follow-up have been published in recent years, so re-evaluation and syntheses of data in existing trials are important.
According to the findings from the present meta-analysis, the following conclusions can be drawn. First, the prevalence of patient satisfaction was similar between LNF and LTF, and was high (LNF, 89.17 %; LTF, 87.42 %). Second, LTF was as effective as LNF with respect to symptom control. Third, the prevalence of postoperative dysphagia was higher after LNF, but with increasing duration of follow-up, the difference between two arms disappeared. Fourth, LNF was associated with higher LES pressure.
This report demonstrated that the operating time of LTF was longer than that of LNF, which might be due to the fact that the gastric fundus and both sides of the esophagus should be secured, respectively. Prevalence of perioperative complications between the two groups was not significantly different. But it is notable that Strate et al. [27] and Booth et al. [28] reported a perforation in the fundal wrap and an episode of perioperative bleeding after LTF. And Guérin et al. [26] also observed in-hospital bleeding. This phenomenon may be because the esophagus does not have a serosal layer and gastric fundus and both sides of the esophagus wall need to be sutured together, which may increase the risk of perforation and bleeding.
Heartburn and regurgitation are typical symptoms of GERD. Our report showed that LNF and LTF were similar with regard to reflux control. Importantly, objective parameters are not always in accordance with the symptoms or complaints of patients [27, 36, 37]. The value of laboratory examinations is limited for the diagnosis and evaluation of therapeutic efficacy for GERD, so the definition of “recurrent GERD” based on laboratory measurements alone may not be appropriate. Symptoms combined with objective parameters should be the main indications for surgical therapy, a view that is consistent with that of Tan et al [34].
With better control of GERD, LNF was previously regarded as the standard treatment for GERD. However, this concept has been challenged owing to postoperative functional disorders. We have shown that LNF is associated with a higher incidence of postoperative dysphagia, gas-bloating and inability to belch. However, subgroup analyses suggested that differences in the prevalence of dysphagia between two techniques disappeared over time. Furthermore, two decades follow-up results of a RCT [38] comparing open Nissen and Toupet demonstrated no difference in the prevalence of postoperative complications. As a reasonable and accurate index for assessing the efficacy of surgical treatment for GERD [39, 40], the patient satisfaction was high (≈90 %) and comparable between the two arms.
As for whether preoperative EM was an indication for “tailored therapy”, the subgroup analyses showed that EM was not correlated with postoperative dysphagia, indicating that “tailored therapy” according to EM was not indicated, which was consistent with other reports [30, 33]. It should be noted that the definition of EM in the included studies was not consistent, which might affect the ability to reach true conclusion.
With regard to reoperation, the most common causes were complications, recurrence of reflux symptoms, and others conditions. Specific data could not be obtained, so subgroup analyses based on causes could not be done.
For baseline information’s comparability was uncertain in two studies [19, 27], sensitivity analyses were conducted by removing these two studies for three primary outcomes, thought the results were not altered, which was neglected in previous meta-analyses [3235].
In contrast to previous reviews [3234], some large-scale studies included in our report were published in the last 3 years, and outcomes were evaluated with long-term follow-up (12–60 months). Hence, the results of our meta-analysis are of credibility and stability. The limitations of our meta-analysis were: (i) methodological quality of some studies included in the meta-analysis was poor (lack of blinding and description of randomization processes); (ii) the number of included studies and sample size was small; and (iii) definitions or evaluation criteria in different studies were not consistent.

Conclusions

In conclusion, our meta-analysis suggests that LNF and LTF have equivalently good control of GERD and could result in a similar prevalence of patient satisfaction. It is not rational or advisable to abandon LNF based on current evidence when choosing a surgical procedure for GERD. More large-scale, multicenter, high-quality, RCTs with a longer duration of follow-up are required to further clarify the value of LNF and LTF.

Abbreviations

BMI, body mass index; DSGV, division of short gastric vessels; EM, esophageal motility; GERD, gastro-esophageal reflux disease; HR, high risk; LES, lower esophageal sphincter; LNF, laparoscopic Nissen fundoplication; LR, low risk; LTF, laparoscopic Toupet fundoplication; NR, not report; RCTs, randomized controlled trials; RR, risk ratio; SMD, Standard mean difference; UR, Unclear risk

Acknowledgements

We would like to appreciate the reviewers for their helpful suggestions or comments on this paper.

Funding

There is no funding for the study.

Availability of data and materials

All the data supporting our findings is contained within the manuscript.

Authors’ contributions

XD and ZWH designed the study; XD, ZWH, CY, CZ, ZGW and JMW coordinated the study; XD, ZWH, CY, CZ and ZGW performed the study; CY, CZ and ZGW analyzed the data; ZWH, CY and JMW helped to draft the manuscript; and XD wrote the manuscript. All authors read and approved the final manuscript.

Competing interests

All authors have declared that no competing interests exist.
Not applicable.
Not applicable.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://​creativecommons.​org/​licenses/​by/​4.​0/​), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated.
Literatur
1.
Zurück zum Zitat Vakil N, van Zanten SV, Kahrilas P, Dent J, Jones R. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol. 2006;101(8):1900–20. quiz 1943.CrossRefPubMed Vakil N, van Zanten SV, Kahrilas P, Dent J, Jones R. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol. 2006;101(8):1900–20. quiz 1943.CrossRefPubMed
2.
Zurück zum Zitat El-Serag HB, Sweet S, Winchester CC, Dent J. Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut. 2014;63(6):871–80.CrossRefPubMed El-Serag HB, Sweet S, Winchester CC, Dent J. Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut. 2014;63(6):871–80.CrossRefPubMed
3.
Zurück zum Zitat Hsu YC, Yang TH, Hsu WL, Wu HT, Cheng YC, Chiang MF, Wang CS, Lin HJ. Mosapride as an adjunct to lansoprazole for symptom relief of reflux oesophagitis. Br J Clin Pharmacol. 2010;70(2):171–9.CrossRefPubMedPubMedCentral Hsu YC, Yang TH, Hsu WL, Wu HT, Cheng YC, Chiang MF, Wang CS, Lin HJ. Mosapride as an adjunct to lansoprazole for symptom relief of reflux oesophagitis. Br J Clin Pharmacol. 2010;70(2):171–9.CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Liang WT, Yan C, Wang ZG, Wu JM, Hu ZW, Zhan XL, Wang F, Ma SS, Chen MP. Early and midterm outcome after laparoscopic fundoplication and a minimally invasive endoscopic procedure in patients with gastroesophageal reflux disease: a prospective observational study. J Laparoendosc Adv Surg Tech A. 2015;25(8):657–61.CrossRefPubMed Liang WT, Yan C, Wang ZG, Wu JM, Hu ZW, Zhan XL, Wang F, Ma SS, Chen MP. Early and midterm outcome after laparoscopic fundoplication and a minimally invasive endoscopic procedure in patients with gastroesophageal reflux disease: a prospective observational study. J Laparoendosc Adv Surg Tech A. 2015;25(8):657–61.CrossRefPubMed
5.
Zurück zum Zitat Spechler SJ. Comparison of medical and surgical therapy for complicated gastroesophageal reflux disease in veterans. The Department of Veterans Affairs Gastroesophageal Reflux Disease Study Group. N Engl J Med. 1992;326(12):786–92.CrossRefPubMed Spechler SJ. Comparison of medical and surgical therapy for complicated gastroesophageal reflux disease in veterans. The Department of Veterans Affairs Gastroesophageal Reflux Disease Study Group. N Engl J Med. 1992;326(12):786–92.CrossRefPubMed
6.
Zurück zum Zitat Geagea T. Nissen fundoplication by laparoscopy. Union Med Can. 1991;120:417.PubMed Geagea T. Nissen fundoplication by laparoscopy. Union Med Can. 1991;120:417.PubMed
7.
Zurück zum Zitat Dallemagne B, Weerts JM, Jehaes C, Markiewicz S, Lombard R. Laparoscopic Nissen fundoplication: preliminary report. Surg Laparosc Endosc. 1991;1(3):138–43.PubMed Dallemagne B, Weerts JM, Jehaes C, Markiewicz S, Lombard R. Laparoscopic Nissen fundoplication: preliminary report. Surg Laparosc Endosc. 1991;1(3):138–43.PubMed
8.
Zurück zum Zitat Ruiz-Tovar J, Diez-Tabernilla M, Chames A, Morales V, Martinez-Molina E. Clinical outcome at 10 years after laparoscopic versus open Nissen fundoplication. J Laparoendosc Adv Surg Tech A. 2010;20:21–3.CrossRefPubMed Ruiz-Tovar J, Diez-Tabernilla M, Chames A, Morales V, Martinez-Molina E. Clinical outcome at 10 years after laparoscopic versus open Nissen fundoplication. J Laparoendosc Adv Surg Tech A. 2010;20:21–3.CrossRefPubMed
9.
Zurück zum Zitat Hakanson BS, Thor KB, Thorell A, Ljungqvist O. Open vs laparoscopic partial posterior fundoplication. A prospective randomized trial. Surg Endosc. 2007;21(2):289–98.CrossRefPubMed Hakanson BS, Thor KB, Thorell A, Ljungqvist O. Open vs laparoscopic partial posterior fundoplication. A prospective randomized trial. Surg Endosc. 2007;21(2):289–98.CrossRefPubMed
10.
Zurück zum Zitat Draaisma WA, Buskens E, Bais JE, Simmermacher RK, Rijnhart-de JH, Broeders IA, Gooszen HG. Randomized clinical trial and follow-up study of cost-effectiveness of laparoscopic versus conventional Nissen fundoplication. Br J Surg. 2006;93(6):690–7.CrossRefPubMed Draaisma WA, Buskens E, Bais JE, Simmermacher RK, Rijnhart-de JH, Broeders IA, Gooszen HG. Randomized clinical trial and follow-up study of cost-effectiveness of laparoscopic versus conventional Nissen fundoplication. Br J Surg. 2006;93(6):690–7.CrossRefPubMed
11.
Zurück zum Zitat Korkolis DP, Kapritsou M, Konstantinou EA, Giannakopoulou M, Chrysi MS, Tsakiridou M, Kouloura A, Flamourakis M, Maricosu M, Gontikakis E, Plataniotis G. The impact of laparoscopic Nissen fundoplication on the long-term quality of life in patients with gastroesophageal reflux disease. Gastroenterol Nurs. 2015;38(2):111–5.CrossRefPubMed Korkolis DP, Kapritsou M, Konstantinou EA, Giannakopoulou M, Chrysi MS, Tsakiridou M, Kouloura A, Flamourakis M, Maricosu M, Gontikakis E, Plataniotis G. The impact of laparoscopic Nissen fundoplication on the long-term quality of life in patients with gastroesophageal reflux disease. Gastroenterol Nurs. 2015;38(2):111–5.CrossRefPubMed
12.
Zurück zum Zitat SAGES SOAG. Guidelines for surgical treatment of gastroesophageal reflux disease (GERD). Surg Endosc. 1998;12:186–8.CrossRef SAGES SOAG. Guidelines for surgical treatment of gastroesophageal reflux disease (GERD). Surg Endosc. 1998;12:186–8.CrossRef
13.
Zurück zum Zitat Owers C, Ackroyd R. Management of gastroesophageal reflux disease and hiatus hernia: Overview and authors’ perspective. J Surg. 2013;1:51–8. Owers C, Ackroyd R. Management of gastroesophageal reflux disease and hiatus hernia: Overview and authors’ perspective. J Surg. 2013;1:51–8.
14.
Zurück zum Zitat Mickevicius A, Endzinas Z, Kiudelis M, Jonaitis L, Kupcinskas L, Maleckas A, Pundzius J. Influence of wrap length on the effectiveness of Nissen and Toupet fundoplication: a prospective randomized study. Surg Endosc. 2008;22(10):2269–76.CrossRefPubMed Mickevicius A, Endzinas Z, Kiudelis M, Jonaitis L, Kupcinskas L, Maleckas A, Pundzius J. Influence of wrap length on the effectiveness of Nissen and Toupet fundoplication: a prospective randomized study. Surg Endosc. 2008;22(10):2269–76.CrossRefPubMed
15.
Zurück zum Zitat Watson DI, Jamieson GG, Lally C, Archer S, Bessell JR, Booth M, Cade R, Cullingford G, Devitt PG, Fletcher DR, Hurley J, Kiroff G, Martin CJ, Martin IJ, Nathanson LK, Windsor JA. Multicenter, prospective, double-blind, randomized trial of laparoscopic nissen vs anterior 90 degrees partial fundoplication. Arch Surg. 2004;139(11):1160–7.CrossRefPubMed Watson DI, Jamieson GG, Lally C, Archer S, Bessell JR, Booth M, Cade R, Cullingford G, Devitt PG, Fletcher DR, Hurley J, Kiroff G, Martin CJ, Martin IJ, Nathanson LK, Windsor JA. Multicenter, prospective, double-blind, randomized trial of laparoscopic nissen vs anterior 90 degrees partial fundoplication. Arch Surg. 2004;139(11):1160–7.CrossRefPubMed
16.
Zurück zum Zitat Varin O, Velstra B, De Sutter S, Ceelen W. Total vs partial fundoplication in the treatment of gastroesophageal reflux disease: a meta-analysis. Arch Surg. 2009;144(3):273–8.CrossRefPubMed Varin O, Velstra B, De Sutter S, Ceelen W. Total vs partial fundoplication in the treatment of gastroesophageal reflux disease: a meta-analysis. Arch Surg. 2009;144(3):273–8.CrossRefPubMed
17.
Zurück zum Zitat Ramos RF, Lustosa SA, Almeida CA, Silva CP, Matos D. Surgical treatment of gastroesophageal reflux disease: total or partial fundoplication? systematic review and meta-analysis. Arq Gastroenterol. 2011;48(4):252–60.PubMed Ramos RF, Lustosa SA, Almeida CA, Silva CP, Matos D. Surgical treatment of gastroesophageal reflux disease: total or partial fundoplication? systematic review and meta-analysis. Arq Gastroenterol. 2011;48(4):252–60.PubMed
18.
Zurück zum Zitat Ma S, Qian B, Shang L, Shi R, Zhang G. A meta-analysis comparing laparoscopic partial versus Nissen fundoplication. ANZ J Surg. 2012;82:17–22.CrossRefPubMed Ma S, Qian B, Shang L, Shi R, Zhang G. A meta-analysis comparing laparoscopic partial versus Nissen fundoplication. ANZ J Surg. 2012;82:17–22.CrossRefPubMed
19.
Zurück zum Zitat Qin M, Ding G, Yang H. A clinical comparison of laparoscopic Nissen and Toupet fundoplication for gastroesophageal reflux disease. J Laparoendosc Adv Surg Tech A. 2013;23(7):601–4.CrossRefPubMed Qin M, Ding G, Yang H. A clinical comparison of laparoscopic Nissen and Toupet fundoplication for gastroesophageal reflux disease. J Laparoendosc Adv Surg Tech A. 2013;23(7):601–4.CrossRefPubMed
20.
Zurück zum Zitat Koch OO, Kaindlstorfer A, Antoniou SA, Luketina RR, Emmanuel K, Pointner R. Comparison of results from a randomized trial 1 year after laparoscopic Nissen and Toupet fundoplications. Surg Endosc. 2013;27(7):2383–90.CrossRefPubMed Koch OO, Kaindlstorfer A, Antoniou SA, Luketina RR, Emmanuel K, Pointner R. Comparison of results from a randomized trial 1 year after laparoscopic Nissen and Toupet fundoplications. Surg Endosc. 2013;27(7):2383–90.CrossRefPubMed
21.
Zurück zum Zitat Wang B, Zhang W, Liu S, Du Z, Shan C, Qiu M. A Chinese randomized prospective trial of floppy Nissen and Toupet fundoplication for gastroesophageal disease. Int J Surg. 2015;23(PtA):35–40.CrossRefPubMed Wang B, Zhang W, Liu S, Du Z, Shan C, Qiu M. A Chinese randomized prospective trial of floppy Nissen and Toupet fundoplication for gastroesophageal disease. Int J Surg. 2015;23(PtA):35–40.CrossRefPubMed
22.
Zurück zum Zitat Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg. 2010;8(5):336–41.CrossRefPubMed Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg. 2010;8(5):336–41.CrossRefPubMed
23.
Zurück zum Zitat DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177–88.CrossRefPubMed DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177–88.CrossRefPubMed
24.
Zurück zum Zitat Higgins JP, Altman DG, Gotzsche PC, Juni P, Moher D, Oxman AD, Savovic J, Schulz KF, Weeks L, Sterne JA. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928.CrossRefPubMedPubMedCentral Higgins JP, Altman DG, Gotzsche PC, Juni P, Moher D, Oxman AD, Savovic J, Schulz KF, Weeks L, Sterne JA. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928.CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Chrysos E, Tsiaoussis J, Zoras OJ, Athanasakis E, Mantides A, Katsamouris A, Xynos E. Laparoscopic surgery for gastroesophageal reflux disease patients with impaired esophageal peristalsis: total or partial fundoplication? J Am Coll Surg. 2003;197(1):8–15.CrossRefPubMed Chrysos E, Tsiaoussis J, Zoras OJ, Athanasakis E, Mantides A, Katsamouris A, Xynos E. Laparoscopic surgery for gastroesophageal reflux disease patients with impaired esophageal peristalsis: total or partial fundoplication? J Am Coll Surg. 2003;197(1):8–15.CrossRefPubMed
26.
Zurück zum Zitat Guérin E, Betroune K, Closset J, Mehdi A, Lefebvre JC, Houben JJ, Gelin M, Vaneukem P, El NI. Nissen versus Toupet fundoplication: results of a randomized and multicenter trial. Surg Endosc. 2007;21(11):1985–90.CrossRefPubMed Guérin E, Betroune K, Closset J, Mehdi A, Lefebvre JC, Houben JJ, Gelin M, Vaneukem P, El NI. Nissen versus Toupet fundoplication: results of a randomized and multicenter trial. Surg Endosc. 2007;21(11):1985–90.CrossRefPubMed
27.
Zurück zum Zitat Strate U, Emmermann A, Fibbe C, Layer P, Zornig C. Laparoscopic fundoplication: Nissen versus Toupet two-year outcome of a prospective randomized study of 200 patients regarding preoperative esophageal motility. Surg Endosc. 2008;22:21–30.CrossRefPubMed Strate U, Emmermann A, Fibbe C, Layer P, Zornig C. Laparoscopic fundoplication: Nissen versus Toupet two-year outcome of a prospective randomized study of 200 patients regarding preoperative esophageal motility. Surg Endosc. 2008;22:21–30.CrossRefPubMed
28.
Zurück zum Zitat Booth MI, Stratford J, Jones L, Dehn TC. Randomized clinical trial of laparoscopic total (Nissen) versus posterior partial (Toupet) fundoplication for gastro-oesophageal reflux disease based on preoperative oesophageal manometry. Br J Surg. 2008;95(1):57–63.CrossRefPubMed Booth MI, Stratford J, Jones L, Dehn TC. Randomized clinical trial of laparoscopic total (Nissen) versus posterior partial (Toupet) fundoplication for gastro-oesophageal reflux disease based on preoperative oesophageal manometry. Br J Surg. 2008;95(1):57–63.CrossRefPubMed
29.
Zurück zum Zitat Shaw JM, Bornman PC, Callanan MD, Beckingham IJ, Metz DC. Long-term outcome of laparoscopic Nissen and laparoscopic Toupet fundoplication for gastroesophageal reflux disease: a prospective, randomized trial. Surg Endosc. 2010;24(4):924–32.CrossRefPubMed Shaw JM, Bornman PC, Callanan MD, Beckingham IJ, Metz DC. Long-term outcome of laparoscopic Nissen and laparoscopic Toupet fundoplication for gastroesophageal reflux disease: a prospective, randomized trial. Surg Endosc. 2010;24(4):924–32.CrossRefPubMed
30.
Zurück zum Zitat Mughal MM, Bancewicz J, Marples M. Oesophageal manometry and pH recording does not predict the bad results of Nissen fundoplication. Br J Surg. 1990;77(1):43–5.CrossRefPubMed Mughal MM, Bancewicz J, Marples M. Oesophageal manometry and pH recording does not predict the bad results of Nissen fundoplication. Br J Surg. 1990;77(1):43–5.CrossRefPubMed
31.
Zurück zum Zitat Liang WT, Wu JM, Hu ZW, Wang ZG, Zhu GC, Zhang C. Laparoscopic Nissen fundoplication is more effective in treating patients with GERD-related chronic cough than Stretta radiofrequency. Minerva Chir. 2014;69(3):121–7.PubMed Liang WT, Wu JM, Hu ZW, Wang ZG, Zhu GC, Zhang C. Laparoscopic Nissen fundoplication is more effective in treating patients with GERD-related chronic cough than Stretta radiofrequency. Minerva Chir. 2014;69(3):121–7.PubMed
32.
Zurück zum Zitat Shan CX, Zhang W, Zheng XM, Jiang DZ, Liu S, Qiu M. Evidence-based appraisal in laparoscopic Nissen and Toupet fundoplications for gastroesophageal reflux disease. World J Gastroenterol. 2010;16(24):3063–71.CrossRefPubMedPubMedCentral Shan CX, Zhang W, Zheng XM, Jiang DZ, Liu S, Qiu M. Evidence-based appraisal in laparoscopic Nissen and Toupet fundoplications for gastroesophageal reflux disease. World J Gastroenterol. 2010;16(24):3063–71.CrossRefPubMedPubMedCentral
33.
Zurück zum Zitat Broeders JA, Mauritz FA, Ahmed AU, Draaisma WA, Ruurda JP, Gooszen HG, Smout AJ, Broeders IA, Hazebroek EJ. Systematic review and meta-analysis of laparoscopic Nissen (posterior total) versus Toupet (posterior partial) fundoplication for gastro-oesophageal reflux disease. Br J Surg. 2010;97(9):1318–30.CrossRefPubMed Broeders JA, Mauritz FA, Ahmed AU, Draaisma WA, Ruurda JP, Gooszen HG, Smout AJ, Broeders IA, Hazebroek EJ. Systematic review and meta-analysis of laparoscopic Nissen (posterior total) versus Toupet (posterior partial) fundoplication for gastro-oesophageal reflux disease. Br J Surg. 2010;97(9):1318–30.CrossRefPubMed
34.
Zurück zum Zitat Tan G, Yang Z, Wang Z. Meta-analysis of laparoscopic total (Nissen) versus posterior (Toupet) fundoplication for gastro-oesophageal reflux disease based on randomized clinical trials. ANZ J Surg. 2011;81(4):246–52.CrossRefPubMed Tan G, Yang Z, Wang Z. Meta-analysis of laparoscopic total (Nissen) versus posterior (Toupet) fundoplication for gastro-oesophageal reflux disease based on randomized clinical trials. ANZ J Surg. 2011;81(4):246–52.CrossRefPubMed
35.
Zurück zum Zitat Tian ZC, Wang B, Shan CX, Zhang W, Jiang DZ, Qiu M. A meta-analysis of randomized controlled trials to compare long-term outcomes of Nissen and toupet fundoplication for gastroesophageal reflux disease. PLoS One. 2015;10(6):e0127627.CrossRefPubMedPubMedCentral Tian ZC, Wang B, Shan CX, Zhang W, Jiang DZ, Qiu M. A meta-analysis of randomized controlled trials to compare long-term outcomes of Nissen and toupet fundoplication for gastroesophageal reflux disease. PLoS One. 2015;10(6):e0127627.CrossRefPubMedPubMedCentral
36.
Zurück zum Zitat Fein M, Bueter M, Thalheimer A, Pachmayr V, Heimbucher J, Freys SM, Fuchs KH. Ten-year outcome of laparoscopic antireflux surgery. J Gastrointest Surg. 2008;12(11):1893–9.CrossRefPubMed Fein M, Bueter M, Thalheimer A, Pachmayr V, Heimbucher J, Freys SM, Fuchs KH. Ten-year outcome of laparoscopic antireflux surgery. J Gastrointest Surg. 2008;12(11):1893–9.CrossRefPubMed
37.
Zurück zum Zitat Khajanchee YS, O’Rourke RW, Lockhart B, Patterson EJ, Hansen PD, Swanstrom LL. Postoperative symptoms and failure after antireflux surgery. Arch Surg. 2002;137(9):1008–13. discussion 1013-4.CrossRefPubMed Khajanchee YS, O’Rourke RW, Lockhart B, Patterson EJ, Hansen PD, Swanstrom LL. Postoperative symptoms and failure after antireflux surgery. Arch Surg. 2002;137(9):1008–13. discussion 1013-4.CrossRefPubMed
38.
Zurück zum Zitat Mardani J, Lundell L, Engstrom C. Total or posterior partial fundoplication in the treatment of GERD: results of a randomized trial after 2 decades of follow-up. Ann Surg. 2011;253(5):875–8.CrossRefPubMed Mardani J, Lundell L, Engstrom C. Total or posterior partial fundoplication in the treatment of GERD: results of a randomized trial after 2 decades of follow-up. Ann Surg. 2011;253(5):875–8.CrossRefPubMed
39.
Zurück zum Zitat Kamolz T, Granderath FA, Bammer T, Wykypiel HJ, Pointner R. “Floppy” Nissen vs. Toupet laparoscopic fundoplication: quality of life assessment in a 5-year follow-up (part 2). Endoscopy. 2002;34(11):917–22.CrossRefPubMed Kamolz T, Granderath FA, Bammer T, Wykypiel HJ, Pointner R. “Floppy” Nissen vs. Toupet laparoscopic fundoplication: quality of life assessment in a 5-year follow-up (part 2). Endoscopy. 2002;34(11):917–22.CrossRefPubMed
40.
Zurück zum Zitat Catarci M, Gentileschi P, Papi C, Carrara A, Marrese R, Gaspari AL, Grassi GB. Evidence-based appraisal of antireflux fundoplication. Ann Surg. 2004;239(3):325–37.CrossRefPubMedPubMedCentral Catarci M, Gentileschi P, Papi C, Carrara A, Marrese R, Gaspari AL, Grassi GB. Evidence-based appraisal of antireflux fundoplication. Ann Surg. 2004;239(3):325–37.CrossRefPubMedPubMedCentral
Metadaten
Titel
A meta-analysis of long follow-up outcomes of laparoscopic Nissen (total) versus Toupet (270°) fundoplication for gastro-esophageal reflux disease based on randomized controlled trials in adults
verfasst von
Xing Du
Zhiwei Hu
Chao Yan
Chao Zhang
Zhonggao Wang
Jimin Wu
Publikationsdatum
01.12.2016
Verlag
BioMed Central
Erschienen in
BMC Gastroenterology / Ausgabe 1/2016
Elektronische ISSN: 1471-230X
DOI
https://doi.org/10.1186/s12876-016-0502-8

Weitere Artikel der Ausgabe 1/2016

BMC Gastroenterology 1/2016 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Reizdarmsyndrom: Diäten wirksamer als Medikamente

29.04.2024 Reizdarmsyndrom Nachrichten

Bei Reizdarmsyndrom scheinen Diäten, wie etwa die FODMAP-arme oder die kohlenhydratreduzierte Ernährung, effektiver als eine medikamentöse Therapie zu sein. Das hat eine Studie aus Schweden ergeben, die die drei Therapieoptionen im direkten Vergleich analysierte.

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.